Atorvastatin reduces serum cholesterol and triglycerides with limited improvement in vascular function in adults with sickle cell anemia

This publication has 12 references indexed in Scilit:

• A pilot study of the short‐term use of simvastatin in sickle cell disease: effects on markers of vascular dysfunction
  British Journal of Haematology, 2011
• Pulmonary hypertension and NO in sickle cell
  Blood, 2010
• Levels of soluble endothelium‐derived adhesion molecules in patients with sickle cell disease are associated with pulmonary hypertension, organ dysfunction, and mortality
  British Journal of Haematology, 2005
• Endothelial cell expression of tissue factor in sickle mice is augmented by hypoxia/reoxygenation and inhibited by lovastatin
  Blood, 2004
• Sickle cell anemia is associated with reduced nitric oxide bioactivity in peripheral conduit and resistance vessels
  American Journal of Hematology, 2003
• Rapid effects on vascular function after initiation and withdrawal of atorvastatin in healthy, normocholesterolemic men
  The American Journal of Cardiology, 2001
• Endothelial dysfunction in patients with sickle cell disease is related to selective impairment of shear stress–mediated vasodilation
  Blood, 2001
• Mechanisms of vascular instability in a transgenic mouse model of sickle cell disease
  American Journal of Physiology-Regulatory, Integrative and Comparative Physiology, 2000
• Effects of atorvastatin and vitamin C on endothelial function of hypercholesterolemic patients
  Atherosclerosis, 2000
• Impaired nitric oxide-mediated vasodilation in transgenic sickle mouse
  American Journal of Physiology-Heart and Circulatory Physiology, 2000